Leukaemia drugs hold promise for treatment-resistant lung cancer
Two recently approved leukaemia drugs could be enlisted against treatment-resistant lung cancer, with a clinical…
Browsing: gilteritinib
AACR 2019: Gilteritinib improved survival for patients with acute myeloid leukaemia
Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory…